Stocks and InvestingStocks and Investing
Mon, February 8, 2021
Sat, February 6, 2021
Fri, February 5, 2021
Thu, February 4, 2021

Vamil Divan Maintained (ABBV) at Strong Buy with Increased Target to $126 on, Feb 4th, 2021


Published on 2024-10-27 15:30:20 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Mizuho, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $117 to $126 on, Feb 4th, 2021.

Vamil has made no other calls on ABBV in the last 4 months.



There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 1 agrees with Vamil's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $110 on, Friday, December 11th, 2020


These are the ratings of the 5 analyists that currently disagree with Vamil


  • David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $116 on, Thursday, January 28th, 2021
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $124 on, Friday, December 11th, 2020
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $120 on, Thursday, December 10th, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $120 on, Monday, November 30th, 2020
  • Gary Nachman of "BMO Capital" Initiated at Buy and Held Target at $123 on, Wednesday, November 18th, 2020